Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

D Paolini; R Rossoni; D Guardione; Vincenzo Arena

doi:10.1016/j.jval.2015.09.701

Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

D Paolini^*, R Rossoni, D Guardione, Vincenzo Arena

^*Corresponding author

Research output: Contribution to journal › Article

Abstract

Human epidermal growth factor receptor 2 (HER2) status identification is established by immunohistochemistry and in situ hybridisation (ISH). Silver in situ hybridisation (SISH) is an alternative technique to the fluorescence in situ hybridization (FISH). Both methods are recommended by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2013 guidelines. The primary aim of this analysis is to evaluate the economical and organizational impact by adopting FISH or SISH test for HER2 testing.

Original language	English
Pages (from-to)	361-2-362
Journal	Value in Health
Volume	18
DOIs	https://doi.org/10.1016/j.jval.2015.09.701
Publication status	Published - 2015

Keywords

HER2,Economical

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jval.2015.09.701

Cite this

@article{7401ddd6c391412eb80577fda1be3fda,

title = "Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer",

abstract = "Human epidermal growth factor receptor 2 (HER2) status identification is established by immunohistochemistry and in situ hybridisation (ISH). Silver in situ hybridisation (SISH) is an alternative technique to the fluorescence in situ hybridization (FISH). Both methods are recommended by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2013 guidelines. The primary aim of this analysis is to evaluate the economical and organizational impact by adopting FISH or SISH test for HER2 testing.",

keywords = "HER2,Economical, HER2,Economical",

author = "D Paolini and R Rossoni and D Guardione and Vincenzo Arena",

year = "2015",

doi = "10.1016/j.jval.2015.09.701",

language = "English",

volume = "18",

pages = "361--2--362",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Blackwell Science Incorporated:350 Main Street, Sixth Floor:Malden, MA 02148:(888)661-5800, (781)388-8250, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: (781)388-8232",

}

TY - JOUR

T1 - Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

AU - Paolini, D

AU - Rossoni, R

AU - Guardione, D

AU - Arena, Vincenzo

PY - 2015

Y1 - 2015

N2 - Human epidermal growth factor receptor 2 (HER2) status identification is established by immunohistochemistry and in situ hybridisation (ISH). Silver in situ hybridisation (SISH) is an alternative technique to the fluorescence in situ hybridization (FISH). Both methods are recommended by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2013 guidelines. The primary aim of this analysis is to evaluate the economical and organizational impact by adopting FISH or SISH test for HER2 testing.

AB - Human epidermal growth factor receptor 2 (HER2) status identification is established by immunohistochemistry and in situ hybridisation (ISH). Silver in situ hybridisation (SISH) is an alternative technique to the fluorescence in situ hybridization (FISH). Both methods are recommended by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2013 guidelines. The primary aim of this analysis is to evaluate the economical and organizational impact by adopting FISH or SISH test for HER2 testing.

KW - HER2,Economical

UR - http://hdl.handle.net/10807/122889

U2 - 10.1016/j.jval.2015.09.701

DO - 10.1016/j.jval.2015.09.701

M3 - Article

SN - 1098-3015

VL - 18

SP - 361-2-362

JO - Value in Health

JF - Value in Health

ER -

Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this